お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、合成ペプチド ワクチンの世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に合成ペプチド ワクチン市場を分類しています。
本レポートでは世界の合成ペプチド ワクチン市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Anergis、Antigen Express、Apitope Technology、Artificial Cell Technologies、Benovus Bio、Celgene Corporation、Immatics biotechnologies、Merck、ImmunoCellular Therapeutics、ISA Pharmaceuticals、Lytix Biopharma、Spotlight Innovation、OncoTherapy Science、Peptech、Pharmasyntez、Sumitomo Dainippon Pharma、TapImmune、Targovax

レポートは合成ペプチド ワクチンの主要生産者を調査し、主要地域や国の消費状況も提供します。合成ペプチド ワクチンの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Solution Phase Synthesis (SPS)
    Solid Phase Peptide Synthesis (SPPS)

用途別の市場セグメント：
    Prostate Cancer
    Breast Cancer
    Gastric Cancer
    Lung Cancer
    Pancreatic Cancer
    Others

本レポートの詳細内容
本レポートは、世界の合成ペプチド ワクチン市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて合成ペプチド ワクチン市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の合成ペプチド ワクチン生産量、成長率、市場シェアを調査している。

二. 消費面では、合成ペプチド ワクチンの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの合成ペプチド ワクチン売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の合成ペプチド ワクチン市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本合成ペプチド ワクチンのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：合成ペプチド ワクチンのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 合成ペプチド ワクチンの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける合成ペプチド ワクチンの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章合成ペプチド ワクチンメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：合成ペプチド ワクチンの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：合成ペプチド ワクチンの主要メーカーの概要を提供し、製品の説明と仕様、合成ペプチド ワクチンの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：合成ペプチド ワクチンの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Synthetic peptide vaccines are usually composed of 20–30 amino acids containing the specific epitope of an antigen related to infectious and/or chronic diseases including cancers.

The global Synthetic Peptide Vaccine market is projected to grow from US$ 2679 million in 2024 to US$ 3409.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Synthetic Peptide Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Synthetic Peptide Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Synthetic Peptide Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Synthetic Peptide Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Synthetic Peptide Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Synthetic Peptide Vaccine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Anergis
    Antigen Express
    Apitope Technology
    Artificial Cell Technologies
    Benovus Bio
    Celgene Corporation
    Immatics biotechnologies
    Merck
    ImmunoCellular Therapeutics
    ISA Pharmaceuticals
    Lytix Biopharma
    Spotlight Innovation
    OncoTherapy Science
    Peptech
    Pharmasyntez
    Sumitomo Dainippon Pharma
    TapImmune
    Targovax

Segment by Type
    Solution Phase Synthesis (SPS)
    Solid Phase Peptide Synthesis (SPPS)

Segment by Application
    Prostate Cancer
    Breast Cancer
    Gastric Cancer
    Lung Cancer
    Pancreatic Cancer
    Others

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Synthetic Peptide Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Synthetic Peptide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Synthetic Peptide Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Synthetic Peptide Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Solution Phase Synthesis (SPS)
    Table 3. Major Manufacturers of Solid Phase Peptide Synthesis (SPPS)
    Table 4. Global Synthetic Peptide Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Synthetic Peptide Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Synthetic Peptide Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Synthetic Peptide Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2019-2024)
    Table 9. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2025-2030)
    Table 10. Global Synthetic Peptide Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Synthetic Peptide Vaccine Sales by Region (2019-2024) & (K Dose)
    Table 12. Global Synthetic Peptide Vaccine Sales by Region (2025-2030) & (K Dose)
    Table 13. Global Synthetic Peptide Vaccine Sales Market Share by Region (2019-2024)
    Table 14. Global Synthetic Peptide Vaccine Sales Market Share by Region (2025-2030)
    Table 15. Global Synthetic Peptide Vaccine Sales by Manufacturers (2019-2024) & (K Dose)
    Table 16. Global Synthetic Peptide Vaccine Sales Share by Manufacturers (2019-2024)
    Table 17. Global Synthetic Peptide Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Synthetic Peptide Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Synthetic Peptide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Synthetic Peptide Vaccine Price by Manufacturers 2019-2024 (US$/Dose)
    Table 21. Global Synthetic Peptide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Synthetic Peptide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Peptide Vaccine as of 2023)
    Table 23. Global Key Manufacturers of Synthetic Peptide Vaccine, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Synthetic Peptide Vaccine, Product Offered and Application
    Table 25. Global Key Manufacturers of Synthetic Peptide Vaccine, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Synthetic Peptide Vaccine Sales by Type (2019-2024) & (K Dose)
    Table 28. Global Synthetic Peptide Vaccine Sales by Type (2025-2030) & (K Dose)
    Table 29. Global Synthetic Peptide Vaccine Sales Share by Type (2019-2024)
    Table 30. Global Synthetic Peptide Vaccine Sales Share by Type (2025-2030)
    Table 31. Global Synthetic Peptide Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Synthetic Peptide Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Synthetic Peptide Vaccine Revenue Share by Type (2019-2024)
    Table 34. Global Synthetic Peptide Vaccine Revenue Share by Type (2025-2030)
    Table 35. Synthetic Peptide Vaccine Price by Type (2019-2024) & (US$/Dose)
    Table 36. Global Synthetic Peptide Vaccine Price Forecast by Type (2025-2030) & (US$/Dose)
    Table 37. Global Synthetic Peptide Vaccine Sales by Application (2019-2024) & (K Dose)
    Table 38. Global Synthetic Peptide Vaccine Sales by Application (2025-2030) & (K Dose)
    Table 39. Global Synthetic Peptide Vaccine Sales Share by Application (2019-2024)
    Table 40. Global Synthetic Peptide Vaccine Sales Share by Application (2025-2030)
    Table 41. Global Synthetic Peptide Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Synthetic Peptide Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Synthetic Peptide Vaccine Revenue Share by Application (2019-2024)
    Table 44. Global Synthetic Peptide Vaccine Revenue Share by Application (2025-2030)
    Table 45. Synthetic Peptide Vaccine Price by Application (2019-2024) & (US$/Dose)
    Table 46. Global Synthetic Peptide Vaccine Price Forecast by Application (2025-2030) & (US$/Dose)
    Table 47. US & Canada Synthetic Peptide Vaccine Sales by Type (2019-2024) & (K Dose)
    Table 48. US & Canada Synthetic Peptide Vaccine Sales by Type (2025-2030) & (K Dose)
    Table 49. US & Canada Synthetic Peptide Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Synthetic Peptide Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Synthetic Peptide Vaccine Sales by Application (2019-2024) & (K Dose)
    Table 52. US & Canada Synthetic Peptide Vaccine Sales by Application (2025-2030) & (K Dose)
    Table 53. US & Canada Synthetic Peptide Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Synthetic Peptide Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Synthetic Peptide Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Synthetic Peptide Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Synthetic Peptide Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Synthetic Peptide Vaccine Sales by Country (2019-2024) & (K Dose)
    Table 59. US & Canada Synthetic Peptide Vaccine Sales by Country (2025-2030) & (K Dose)
    Table 60. Europe Synthetic Peptide Vaccine Sales by Type (2019-2024) & (K Dose)
    Table 61. Europe Synthetic Peptide Vaccine Sales by Type (2025-2030) & (K Dose)
    Table 62. Europe Synthetic Peptide Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Synthetic Peptide Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Synthetic Peptide Vaccine Sales by Application (2019-2024) & (K Dose)
    Table 65. Europe Synthetic Peptide Vaccine Sales by Application (2025-2030) & (K Dose)
    Table 66. Europe Synthetic Peptide Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Synthetic Peptide Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Synthetic Peptide Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Synthetic Peptide Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Synthetic Peptide Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Synthetic Peptide Vaccine Sales by Country (2019-2024) & (K Dose)
    Table 72. Europe Synthetic Peptide Vaccine Sales by Country (2025-2030) & (K Dose)
    Table 73. China Synthetic Peptide Vaccine Sales by Type (2019-2024) & (K Dose)
    Table 74. China Synthetic Peptide Vaccine Sales by Type (2025-2030) & (K Dose)
    Table 75. China Synthetic Peptide Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Synthetic Peptide Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Synthetic Peptide Vaccine Sales by Application (2019-2024) & (K Dose)
    Table 78. China Synthetic Peptide Vaccine Sales by Application (2025-2030) & (K Dose)
    Table 79. China Synthetic Peptide Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Synthetic Peptide Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Synthetic Peptide Vaccine Sales by Type (2019-2024) & (K Dose)
    Table 82. Asia Synthetic Peptide Vaccine Sales by Type (2025-2030) & (K Dose)
    Table 83. Asia Synthetic Peptide Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Synthetic Peptide Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Synthetic Peptide Vaccine Sales by Application (2019-2024) & (K Dose)
    Table 86. Asia Synthetic Peptide Vaccine Sales by Application (2025-2030) & (K Dose)
    Table 87. Asia Synthetic Peptide Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Synthetic Peptide Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Synthetic Peptide Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Synthetic Peptide Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Synthetic Peptide Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Synthetic Peptide Vaccine Sales by Region (2019-2024) & (K Dose)
    Table 93. Asia Synthetic Peptide Vaccine Sales by Region (2025-2030) & (K Dose)
    Table 94. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Type (2019-2024) & (K Dose)
    Table 95. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Type (2025-2030) & (K Dose)
    Table 96. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Application (2019-2024) & (K Dose)
    Table 99. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Application (2025-2030) & (K Dose)
    Table 100. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Country (2019-2024) & (K Dose)
    Table 106. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales by Country (2025-2030) & (K Dose)
    Table 107. Anergis Company Information
    Table 108. Anergis Description and Major Businesses
    Table 109. Anergis Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 110. Anergis Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Anergis Recent Developments
    Table 112. Antigen Express Company Information
    Table 113. Antigen Express Description and Major Businesses
    Table 114. Antigen Express Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 115. Antigen Express Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Antigen Express Recent Developments
    Table 117. Apitope Technology Company Information
    Table 118. Apitope Technology Description and Major Businesses
    Table 119. Apitope Technology Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 120. Apitope Technology Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Apitope Technology Recent Developments
    Table 122. Artificial Cell Technologies Company Information
    Table 123. Artificial Cell Technologies Description and Major Businesses
    Table 124. Artificial Cell Technologies Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 125. Artificial Cell Technologies Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Artificial Cell Technologies Recent Developments
    Table 127. Benovus Bio Company Information
    Table 128. Benovus Bio Description and Major Businesses
    Table 129. Benovus Bio Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 130. Benovus Bio Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Benovus Bio Recent Developments
    Table 132. Celgene Corporation Company Information
    Table 133. Celgene Corporation Description and Major Businesses
    Table 134. Celgene Corporation Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 135. Celgene Corporation Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Celgene Corporation Recent Developments
    Table 137. Immatics biotechnologies Company Information
    Table 138. Immatics biotechnologies Description and Major Businesses
    Table 139. Immatics biotechnologies Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 140. Immatics biotechnologies Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Immatics biotechnologies Recent Developments
    Table 142. Merck Company Information
    Table 143. Merck Description and Major Businesses
    Table 144. Merck Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 145. Merck Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Merck Recent Developments
    Table 147. ImmunoCellular Therapeutics Company Information
    Table 148. ImmunoCellular Therapeutics Description and Major Businesses
    Table 149. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 150. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. ImmunoCellular Therapeutics Recent Developments
    Table 152. ISA Pharmaceuticals Company Information
    Table 153. ISA Pharmaceuticals Description and Major Businesses
    Table 154. ISA Pharmaceuticals Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 155. ISA Pharmaceuticals Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. ISA Pharmaceuticals Recent Developments
    Table 157. Lytix Biopharma Company Information
    Table 158. Lytix Biopharma Description and Major Businesses
    Table 159. Lytix Biopharma Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 160. Lytix Biopharma Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Lytix Biopharma Recent Developments
    Table 162. Spotlight Innovation Company Information
    Table 163. Spotlight Innovation Description and Major Businesses
    Table 164. Spotlight Innovation Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 165. Spotlight Innovation Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Spotlight Innovation Recent Developments
    Table 167. OncoTherapy Science Company Information
    Table 168. OncoTherapy Science Description and Major Businesses
    Table 169. OncoTherapy Science Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 170. OncoTherapy Science Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. OncoTherapy Science Recent Developments
    Table 172. Peptech Company Information
    Table 173. Peptech Description and Major Businesses
    Table 174. Peptech Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 175. Peptech Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. Peptech Recent Developments
    Table 177. Pharmasyntez Company Information
    Table 178. Pharmasyntez Description and Major Businesses
    Table 179. Pharmasyntez Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 180. Pharmasyntez Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 181. Pharmasyntez Recent Developments
    Table 182. Sumitomo Dainippon Pharma Company Information
    Table 183. Sumitomo Dainippon Pharma Description and Major Businesses
    Table 184. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 185. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 186. Sumitomo Dainippon Pharma Recent Developments
    Table 187. TapImmune Company Information
    Table 188. TapImmune Description and Major Businesses
    Table 189. TapImmune Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 190. TapImmune Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 191. TapImmune Recent Developments
    Table 192. Targovax Company Information
    Table 193. Targovax Description and Major Businesses
    Table 194. Targovax Synthetic Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
    Table 195. Targovax Synthetic Peptide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 196. Targovax Recent Developments
    Table 197. Key Raw Materials Lists
    Table 198. Raw Materials Key Suppliers Lists
    Table 199. Synthetic Peptide Vaccine Distributors List
    Table 200. Synthetic Peptide Vaccine Customers List
    Table 201. Synthetic Peptide Vaccine Market Trends
    Table 202. Synthetic Peptide Vaccine Market Drivers
    Table 203. Synthetic Peptide Vaccine Market Challenges
    Table 204. Synthetic Peptide Vaccine Market Restraints
    Table 205. Research Programs/Design for This Report
    Table 206. Key Data Information from Secondary Sources
    Table 207. Key Data Information from Primary Sources
List of Figures
    Figure 1. Synthetic Peptide Vaccine Product Picture
    Figure 2. Global Synthetic Peptide Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Synthetic Peptide Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Solution Phase Synthesis (SPS) Product Picture
    Figure 5. Solid Phase Peptide Synthesis (SPPS) Product Picture
    Figure 6. Global Synthetic Peptide Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Synthetic Peptide Vaccine Market Share by Application in 2023 & 2030
    Figure 8. Prostate Cancer
    Figure 9. Breast Cancer
    Figure 10. Gastric Cancer
    Figure 11. Lung Cancer
    Figure 12. Pancreatic Cancer
    Figure 13. Others
    Figure 14. Synthetic Peptide Vaccine Report Years Considered
    Figure 15. Global Synthetic Peptide Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Synthetic Peptide Vaccine Revenue 2019-2030 (US$ Million)
    Figure 17. Global Synthetic Peptide Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 18. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2019-2030)
    Figure 19. Global Synthetic Peptide Vaccine Sales 2019-2030 ((K Dose)
    Figure 20. Global Synthetic Peptide Vaccine Sales Market Share by Region (2019-2030)
    Figure 21. US & Canada Synthetic Peptide Vaccine Sales YoY (2019-2030) & (K Dose)
    Figure 22. US & Canada Synthetic Peptide Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Europe Synthetic Peptide Vaccine Sales YoY (2019-2030) & (K Dose)
    Figure 24. Europe Synthetic Peptide Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. China Synthetic Peptide Vaccine Sales YoY (2019-2030) & (K Dose)
    Figure 26. China Synthetic Peptide Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Asia (excluding China) Synthetic Peptide Vaccine Sales YoY (2019-2030) & (K Dose)
    Figure 28. Asia (excluding China) Synthetic Peptide Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales YoY (2019-2030) & (K Dose)
    Figure 30. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 31. The Synthetic Peptide Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 32. The Top 5 and 10 Largest Manufacturers of Synthetic Peptide Vaccine in the World: Market Share by Synthetic Peptide Vaccine Revenue in 2023
    Figure 33. Global Synthetic Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 34. Global Synthetic Peptide Vaccine Sales Market Share by Type (2019-2030)
    Figure 35. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2019-2030)
    Figure 36. Global Synthetic Peptide Vaccine Sales Market Share by Application (2019-2030)
    Figure 37. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Synthetic Peptide Vaccine Sales Market Share by Type (2019-2030)
    Figure 39. US & Canada Synthetic Peptide Vaccine Revenue Market Share by Type (2019-2030)
    Figure 40. US & Canada Synthetic Peptide Vaccine Sales Market Share by Application (2019-2030)
    Figure 41. US & Canada Synthetic Peptide Vaccine Revenue Market Share by Application (2019-2030)
    Figure 42. US & Canada Synthetic Peptide Vaccine Revenue Share by Country (2019-2030)
    Figure 43. US & Canada Synthetic Peptide Vaccine Sales Share by Country (2019-2030)
    Figure 44. U.S. Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 45. Canada Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 46. Europe Synthetic Peptide Vaccine Sales Market Share by Type (2019-2030)
    Figure 47. Europe Synthetic Peptide Vaccine Revenue Market Share by Type (2019-2030)
    Figure 48. Europe Synthetic Peptide Vaccine Sales Market Share by Application (2019-2030)
    Figure 49. Europe Synthetic Peptide Vaccine Revenue Market Share by Application (2019-2030)
    Figure 50. Europe Synthetic Peptide Vaccine Revenue Share by Country (2019-2030)
    Figure 51. Europe Synthetic Peptide Vaccine Sales Share by Country (2019-2030)
    Figure 52. Germany Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 53. France Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 54. U.K. Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 55. Italy Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 56. Russia Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 57. China Synthetic Peptide Vaccine Sales Market Share by Type (2019-2030)
    Figure 58. China Synthetic Peptide Vaccine Revenue Market Share by Type (2019-2030)
    Figure 59. China Synthetic Peptide Vaccine Sales Market Share by Application (2019-2030)
    Figure 60. China Synthetic Peptide Vaccine Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Synthetic Peptide Vaccine Sales Market Share by Type (2019-2030)
    Figure 62. Asia Synthetic Peptide Vaccine Revenue Market Share by Type (2019-2030)
    Figure 63. Asia Synthetic Peptide Vaccine Sales Market Share by Application (2019-2030)
    Figure 64. Asia Synthetic Peptide Vaccine Revenue Market Share by Application (2019-2030)
    Figure 65. Asia Synthetic Peptide Vaccine Revenue Share by Region (2019-2030)
    Figure 66. Asia Synthetic Peptide Vaccine Sales Share by Region (2019-2030)
    Figure 67. Japan Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 68. South Korea Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 69. China Taiwan Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 70. Southeast Asia Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 71. India Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 72. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America Synthetic Peptide Vaccine Revenue Share by Country (2019-2030)
    Figure 77. Middle East, Africa and Latin America Synthetic Peptide Vaccine Sales Share by Country (2019-2030)
    Figure 78. Brazil Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 79. Mexico Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 80. Turkey Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 81. Israel Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 82. GCC Countries Synthetic Peptide Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 83. Synthetic Peptide Vaccine Value Chain
    Figure 84. Synthetic Peptide Vaccine Production Process
    Figure 85. Channels of Distribution
    Figure 86. Distributors Profiles
    Figure 87. Bottom-up and Top-down Approaches for This Report
    Figure 88. Data Triangulation
    Figure 89. Key Executives Interviewed